CreativeOne Wealth’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87K Hold
218
– – ﹤0.01% 1189
2026
Q1
$5.73K Buy
+218
New +$27.4K ﹤0.01% 1171
2023
Q4
– Sell
-347
Closed -$23K – 640
2023
Q3
$23K Sell
347
-46
-12% -$4.24K ﹤0.01% 564
2023
Q2
$38K Sell
393
-2
-0.5% -$199 ﹤0.01% 821
2023
Q1
$40K Buy
395
+33
+9% +$5.05K ﹤0.01% 785
2022
Q4
$63K Buy
362
+30
+9% +$19.8K ﹤0.01% 724
2022
Q3
$318K Sell
332
-84
-20% -$83.4K 0.02% 516
2022
Q2
$279K Sell
416
-10
-2% -$6.2K 0.02% 582
2022
Q1
$295K Buy
426
+8
+2% +$6.17K 0.02% 581
2021
Q4
$378K Buy
418
+21
+5% +$20K 0.02% 527
2021
Q3
$400K Buy
397
+141
+55% +$104K 0.02% 466
2021
Q2
$167K Buy
256
+67
+35% +$46.5K 0.01% 649
2021
Q1
$140K Buy
+189
New +$152K 0.01% 548

Other funds holding GOSS

CreativeOne Wealth's GOSS Position: Q2 2026 in Review

CreativeOne Wealth held its Gossamer Bio (GOSS) position steady in Q2 2026 at 218 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

CreativeOne Wealth first reported a position in GOSS in Q1 2021 and has held it in 13 quarters since. The position peaked at $400K in Q3 2021. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • CreativeOne Wealth held 218 shares of Gossamer Bio worth $2.87K as of Q2 2026.
  • CreativeOne Wealth left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of CreativeOne Wealth's portfolio in Q2 2026, its #1189 holding.
  • CreativeOne Wealth first reported a position in Gossamer Bio in Q1 2021 and has held it in 13 quarters since.
  • CreativeOne Wealth's Gossamer Bio position peaked at $400K in Q3 2021.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.